Table 1.
Maximum vasoconstriction response (Emax) to phenylephrine in aortic preparations from SS.13BN and Dahl SS rats with or without the perivascular adipose tissue or the endothelium in the presence or absence of NOS inhibition with l-NAME
Aortic Preparation | SS.13BN | Dahl SS |
---|---|---|
Emax; % Increase in Force Response to Phenylephrine | ||
−PVAT+ENDO | 109.2 ± 6.6 | 154.2 ± 9.0* |
+PVAT+ENDO | 70.6 ± 8.5† | 69.0 ± 5.0† |
+PVAT-ENDO | 103.3 ± 10.0§ | 151.8 ± 10.1*§ |
−PVAT-ENDO | 116.1 ± 7.4 | 148.9 ± 17.3 |
+PVAT+ENDO+l-NAME | 97.9 ± 10.8§ | 174.8 ± 14.9*§ |
−PVAT+ENDO+l-NAME | 121.2 ± 12.3 | 139.6 ± 10.4 |
Values are expressed as means ± SE. PVAT, perivascular adipose tissue; ENDO, endothelium; NOS, nitric oxide synthase; l-NAME, Nω-Nitro-[SCAP]L[R]-arginine methyl ester.
P < 0.05 vs. respective SS.13BN aortic preparation;
P < 0.05 vs. −PVAT+ENDO within same rat strain;
P < 0.05 vs. +PVAT+ENDO within same rat strain.
For SS.13BN rats, n = 8–10. For Dahl SS rats, n = 5–9.